<?xml version="1.0"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>CSC Press Releases</title>
    <link>http://www.californiastemcell.com/cgi-bin/pressrel</link>
    <description></description>
    <ttl>1440</ttl>
    <dc:publisher>California Stem Cell, Inc.</dc:publisher>

<item>
  <title>INDUSTRY CONSULTANT GREGORY BONFIGLIO JOINS CALIFORNIA STEM CELL BOARD OF DIRECTORS</title>
  <description></description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20120517</link>
  <pubDate>Thursday, 17 May 2012 05:30:00 -0700</pubDate>
</item>	
	
<item>
  <title>CALIFORNIA STEM CELL CHAIRMAN HANS KEIRSTEAD SPEAKS AT PROMINENT GLOBAL EMERGING LEADERSHIP FORUM</title>
  <description></description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20120412</link>
  <pubDate>Thursday, 12 April 2012 08:30:00 -0700</pubDate>
</item>
	
<item>
  <title>CALIFORNIA STEM CELL CHAIRMAN HANS KEIRSTEAD WEIGHS IN ON GERON NEWS</title>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20111115</link>
  <pubDate>Tuesday, 15 November 2011 13:29:02 -0800</pubDate>
</item>

<item>
  <title>CALIFORNIA STEM CELL CHAIRMAN HANS S. KEIRSTEAD, PH.D. ONE OF SIX LEADING INNOVATORS IN THE HEALTH INDUSTRY</title>
  <description></description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20111102</link>
  <pubDate>Wednesday, 02 November 2011 00:23:08 -0700</pubDate>
</item>

<item>
  <title>CALIFORNIA STEM CELL ACQUIRES CANCER STEM CELL THERAPY PROGRAM</title>
  <description>California Stem Cell, Inc. expands therapeutics program to include a cell therapy for malignant melanoma.</description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20111025</link>
  <pubDate>Tuesday, 25 October 2011 05:11:40 -0700</pubDate>
</item>

<item>
  <title>CALIFORNIA STEM CELL LEADERS KEIRSTEAD AND AIRRIESS SCHEDULED TO SPEAK AT LEADING STEM CELL CONFERENCES</title>
  <description>Hans S. Keirstead, Ph.D. and Chris Airriess, Ph.D. scheduled to address four prominent stem cell conferences in coming weeks.</description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20110913</link>
  <pubDate>Tuesday, 13 September 2011 06:39:33 -0700</pubDate>
</item>

<item>
  <title>CALIFORNIA STEM CELL LEADERS KEIRSTEAD AND AIRRIESS PANELISTS AT ADVOCACY AND THOUGHT LEADER CONFERENCES</title>
  <description>CSC Scientific Advisory Board Chairman and Chief Operating Officer are speaking at two significant advocacy and academic conferences in late June: The Families of Spinal Muscular Atrophy (FSMA) Conference, June 23 - 26, 2011 and the Aspen Ideas Festival, June 27- July 3, 2011.</description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20110625</link>
  <pubDate>Saturday, 25 June 2011 14:42:49 -0700</pubDate>
</item>

<item>
  <title>CALIFORNIA STEM CELL, INC. EARNS ACADEMIC HONORS, INDUSTRY AND GOVERNMENT NOTICE - DRS. KEIRSTEAD AND POOLE FOCUS INTERNATIONAL ATTENTION ON HESC SCIENCE AND MEDICINE</title>
  <description>California Stem Cell, Inc (CSC) will be giving three scientific poster presentations during the 9th Annual Meeting of the International Society for Stem Cell Research (ISSCR) held June 15-18, 2011. Drs. Keirstead and Poole will be traveling later this month to the University of Nis, Serbia where Keirstead will be honored with the title of Visiting Professor, by the Dean of the School of Medicine. </description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20110614</link>
  <pubDate>Tuesday, 14 June 2011 11:39:19 -0700</pubDate>
</item>


<item>
  <title>BRAIN CELLS DERIVED FROM HESCS IN HIGH PURITY; DERIVATION OF HIGH PURITY NEURONAL PROGENITORS FROM HUMAN EMBRYONIC STEM CELLS DEMONSTRATED </title>
  <description>California Stem Cell announced today that the manuscript, “Derivation of High Purity Neuronal Progenitors from Human Embryonic Stem Cells,” has been accepted by PLos ONE for publication. The manuscript and research was prepared in conjunction with the University of California at Irvine and Pfizer Corporation. </description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20110607</link>
  <pubDate>Tuesday, 07 June 2011 11:39:19 -0700</pubDate>
</item>


<item>
  <title>DISTINGUISHED SCIENTIST SPEAKS ON STEM CELL RESEARCH CHALLENGES AND OPPORTUNITIES AT THE BURRILL LATIN AMERICA LIFE SCIENCES CONFERENCE</title>
  <description>Dr. Hans Keirstead in a keynote address will discuss the hurdles faced in winning regulatory approval for the first human embryonic stem cell trial for spinal cord injury.</description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20110509</link>
  <pubDate>Monday, 09 May 2011 13:04:26 -0700</pubDate>
</item>


<item>
  <title>MOTOR NEURONS SPARED IN SMA, ALS AND SPINAL CORD INJURY MODELS, PROGENITOR TRANSPLANTATION DEMONSTRATES MOTOR NEURONS SPARING </title>
  <description>We’ve taken a critical step forward in directing stem cell differentiation, and illustrating their ability to spare spinal cord cells from loss after injury or disease," said Hans Keirstead, Ph.D. This will be a powerful treatment strategy for diseases characterized by motor neuron loss such as ALS, SMA and spinal cord injury.</description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20110512</link>
  <pubDate>Thursday, 12 May 2011 16:48:30 -0700</pubDate>
</item>


<item>
  <title>CIRM TO GIVE $25M FOR FIRST HUMAN STEM CELL TRIALS, KEIRSTEAD’S NOVEL SPINAL CORD THERAPY TO BE TESTED IN DAMAGED SPINES </title>
  <description>The California Institute for Regenerative Medicine (CIRM) has announced that it will give $25 million to a clinical trial that will test an embryonic stem cell-based therapy for spinal cord injuries. The trial is the first to test a therapy based on human embryonic stem cells. </description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20110506</link>
  <pubDate>Friday, 06 May 2011 12:52:16 -0700</pubDate>
</item>


<item>
  <title>LONZA AND CALIFORNIA STEM CELL, INC. INTRODUCE MOTORPLATE™ HUMAN ESC-DERIVED MOTOR NEURON PROGENITORS</title>
  <description></description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20110208</link>
  <pubDate>Tuesday, 08 February 2011 13:29:39 -0800</pubDate>
</item>
 
<item>
  <title>MOTORGRAFT™ CLINICAL TRIAL FOR SMA PLACED ON FDA CLINICAL HOLD.</title>
  <description></description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20110207</link>
  <pubDate>Monday, 07 February 2011 14:00:20 -0800</pubDate>
</item>

<item>
  <title>CALIFORNIA STEM CELL, INC. FILES IND TO COMMENCE PHASE I CLINICAL TRIAL IN SPINAL MUSCULAR ATROPHY </title>
  <description></description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20101201</link>
  <pubDate>Wednesday, 01 December 2010 05:56:09 -0800</pubDate>
</item>

<item>
  <title>Technology invented by CSC SAB members Keirstead and Nistor treats first spinal chord injured patient in Atlanta</title>
  <description>Geron Initiates Clinical Trial Of Human Embryonic Stem Cell-Based Therapy</description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20101011</link>
  <pubDate>Monday, 11 October 2010 14:17:47 -0700</pubDate>
</item>


<item>
  <title>FIRST CLINICAL TRIAL INVOLVING HUMAN EMBRYONIC STEM CELLS GETS UNDERWAY IN CHICAGO</title>
  <description>Enrolment begins for spinal cord injury treatment using cells differentiated by CSC SAB members Keirstead and Nistor </description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20100922</link>
  <pubDate>Wednesday, 22 September 2010 12:48:44 -0700</pubDate>
</item>


<item>
  <title>SPINAL CORD INJURY TREATMENT INVENTED BY CSC SCIENTIFIC ADVISORY BOARD MEMBERS KEIRSTEAD AND NISTOR GOES TO CLINIC</title>
  <description>Geron to Proceed with First Human Clinical Trial of Embryonic Stem Cell-Based Therapy</description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20100802</link>
  <pubDate>Monday, 02 August 2010 10:10:34 -0700</pubDate>
</item>

<item>
  <title>FAMILIES OF SPINAL MUSCULAR ATROPHY AND CALIFORNIA STEM CELL, INC. MOTORGRAFT™ PROJECT 2010 UPDATE</title>
  <description>Families of SMA in collaboration with California Stem Cell, Inc.  and the University of California, Irvine, make significant progress in Motor Neuron Program for Spinal Muscular Atrophy.</description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20100623</link>
  <pubDate>Wednesday, 23 June 2010 09:43:14 -0700</pubDate>
</item>

<item>
  <title>LONZA ANNOUNCES WORLDWIDE, EXCLUSIVE LICENSING AND SUPPLY AGREEMENTS WITH CALIFORNIA STEM CELL, INC.</title>
  <description>Multi-National Distribution to Bring CSC Media and Cells to Global Market.</description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20100607</link>
  <pubDate>Monday, 07 June 2010 07:45:35 -0700</pubDate>
</item>

<item>
  <title>CSC SAB MEMBERS HANS S. KEIRSTEAD AND GABRIEL NISTOR CREATE RETINA FROM HUMAN EMBRYONIC STEM CELLS</title>
  <description>Complex tissue structure offers hope to millions with degenerative eye disorders</description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20100526</link>
  <pubDate>Wednesday, 26 May 2010 16:14:32 -0700</pubDate>
</item>

<item>
  <title>CSC SCIENTIST RECEIVES LLOYD GUTH AWARD FOR EXCELLENCE IN GRADUATE RESEARCH IN SPINAL CORD INJURY</title>
  <description>Dr. Monica Siegenthaler lauded for her work in age-associated myelin pathogenesis and exercise attenuating functional deficits following spinal cord injury.</description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20100524</link>
  <pubDate>Monday, 24 May 2010 11:30:19 -0700</pubDate>
</item>

<item>
  <title>CALIFORNIA STEM CELL SAB CHAIRMAN HANS KEIRSTEAD WINS 2010 MATHILDE SOLOWEY LECTURE AWARD IN THE NEUROSCIENCES</title>
  <description>Prestigious award given for outstanding work in the field of neuroscience.</description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20100225</link>
  <pubDate>Thursday, 25 February 2010 16:28:28 -0800</pubDate>
</item>

<item>
  <title>CALIFORNIA STEM CELL AND ALS THERAPY DEVELOPMENT INSTITUTE EXTEND THEIR COLLABORATION TO ADVANCE POTENTIAL STEM CELL ASSISTED THERAPY FOR ALS</title>
  <description>Collaboration will further evaluate novel stem cell-derived product for the treatment of fatal neurodegenerative disease by regulating genes relevant to disease progression</description>
  <link>http://www.californiastemcell.com/cgi-bin/pressrel?20100202</link>
  <pubDate>Tuesday, 02 February 2010 05:00:00 -0800</pubDate>
</item>

<item>
<title>CALIFORNIA STEM CELL, INC CLOSES SERIES B FINANCING ROUND</title>
<description>Investment to Enable Advancement of Therapeutic and Commercial Aims</description>
<link>http://www.californiastemcell.com/cgi-bin/pressrel?091221</link>
<pubDate>Monday, 21 December 2009 08:30:00 -0800</pubDate>
</item>

<item>
<title>STEM CELL BASED TREATMENT FOR SPINAL MUSCULAR ATROPHY RECEIVES ORPHAN DRUG DESIGNATION</title>
<description>California Stem Cell, Inc And Families Of Spinal Muscular Atrophy Reach Significant Milestone In Development Of Motor Neuron Treatment For SMA</description>
<link>http://www.californiastemcell.com/cgi-bin/pressrel?091208</link><pubDate>Tuesday, 8 December 2009 09:00:00 -0800</pubDate>
</item>


<item>
<title>CALIFORNIA STEM CELL, INC. AND FAMILIES OF SPINAL MUSCULAR ATROPHY ANNOUNCE COMPLETION OF PRE-IND MEETING WITH FDA FOR STEM CELL-DERIVED THERAPY FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY TYPE I</title>
<description>Significant Progress made Towards Moving Novel Therapy into Human Clinical Trials</description>
<link>http://www.californiastemcell.com/cgi-bin/pressrel?091014</link>
<pubDate>Wednesday, 14 October 2009 05:00:00 -0700</pubDate>
</item>


<item>
<title>CALIFORNIA STEM CELL AND STEMINA BIOMARKER DISCOVERY ANNOUNCE COLLABORATION TO VALIDATE EFFECTIVENESS OF HUMAN EMBRYONIC STEM CELL-DERIVED CARDIOMYOCYTE PROGENITORS FOR USE IN PREDICTIVE TOXICOLOGY</title>
<link>http://www.californiastemcell.com/cgi-bin/pressrel?090917</link>
<description>CardioPlate™ 96-well assay-ready plates enable predictive toxicology and high throughput screening assays...</description>
<pubDate>Thursday, 17 September 2009 05:30:00 -0700</pubDate>
<author></author>
</item>

 
<item>
<title>THERAPEUTIC APPROACH DEVELOPED BY CSC SCIENTIFIC ADVISORY BOARD MEMBERS ACHEIVES PRIMARY ENDPOINT IN PHASE 2 TRIAL FOR RHEUMATOID ARTHRITIS</title>
<link>http://www.californiastemcell.com/cgi-bin/pressrel?090514</link>
<description>Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial ...</description>
<pubDate>Thursday, 14 May 2009 08:33:28 -0800</pubDate>
<author></author>
</item>
 
      <item>
      <title>FAMILIES OF SPINAL MUSCULAR ATROPHY AND CALIFORNIA STEM CELL ANNOUNCE EXTENSION OF THEIR COLLABORATION TO ADVANCE POTENTIAL STEM CELL THERAPY FOR SMA</title>
      <link>http://www.californiastemcell.com/cgi-bin/pressrel?042809</link>
      <description>Funding Awarded from The Dhont Family Foundation to Families of Spinal Muscular Atrophy for $180,000 to Achieve Submission of Investigational New Drug (IND) Application to the FDA. ...</description>
      <pubDate>Tuesday, 28 Apr 2009 08:33:28 -0800</pubDate>
      <author></author>
    </item>
    
    <item>
      <title>SPINAL CORD INJURY TREATMENT INVENTED AND CO-DEVELOPED BY CSC SCIENTIFIC ADVISORY BOARD MEMBERS HANS KEIRSTEAD AND GABRIEL NISTOR CLEARED TO BEGIN HUMAN TRIALS</title>
      <link>http://www.californiastemcell.com/cgi-bin/pressrel?09012301</link>
      <description>World's first embryonic stem cell based treatment has received FDA clearance to begin clinical trial...</description>
      <pubDate>Fri, 23 Jan 2009 08:33:28 -0800</pubDate>
      <author></author>
    </item>
 
    <item>
      <title>FAMILIES OF SPINAL MUSCULAR ATROPHY FUNDED STEM CELL MOTOR NEURON REPLACEMENT PROGRAM</title>
      <link>http://www.californiastemcell.com/cgi-bin/pressrel?123008</link>
      <description>FSMA has invested $1.5 Million to develop a motor neuron replacement therapy for SMA, resulting in...</description>
      <pubDate>Tue, 30 Dec 2008 16:33:28 -0800</pubDate>
      <author></author>
    </item>
  
    <item>
      <title>ALS THERAPY DEVELOPMENT INSTITUTE AND CALIFORNIA STEM CELL, INC. ANNOUNCE LONG-TERM SCIENTIFIC COLLABORATION</title>
      <link>http://www.californiastemcell.com/cgi-bin/pressrel?1217347869</link>
      <description>ALS Therapy Development Institute (ALS TDI) and California Stem Cell, Inc (CSC) announced today a new...</description>
      <pubDate>Wed, 31 Dec 1969 16:33:28 -0800</pubDate>
      <author></author>
    </item>

    <item>
      <title>FIRST STEM CELL TRIALS MIGHT START IN O.C.</title>
      <link>http://www.californiastemcell.com/cgi-bin/pressrel?1215128679</link>
      <description>A tiny start-up company in Irvine has a shot at becoming the first to gain federal approval to test an...</description>
      <pubDate>Wed, 31 Dec 1969 16:33:28 -0800</pubDate>
      <author></author>
    </item>

    <item>
      <title>HOW STEM CELLS COULD FIGHT LOU GEHRIG'S DISEASE</title>
      <link>http://www.californiastemcell.com/cgi-bin/pressrel?1212089178</link>
      <description>Patients with Lou Gehrig's disease face a dismal prognosis. The only approved drug, Sanofi-Aventis's...</description>
      <pubDate>Wed, 31 Dec 1969 16:33:28 -0800</pubDate>
      <author></author>
    </item>

    <item>
      <title>COMPANIES RACING TO USE STEM CELLS TO FIND AND TEST NEW DRUGS</title>
      <link>http://www.californiastemcell.com/cgi-bin/pressrel?1212098859</link>
      <description>Two companies that produce different types of stem cells have signed contacts to sell their products...</description>
      <pubDate>Wed, 31 Dec 1969 16:33:28 -0800</pubDate>
      <author></author>
    </item>

    <item>
      <title>CALIFORNIA STEM CELL AND BIOFOCUS DPI TO COLLABORATE IN ALS ASSOCIATION-FUNDED RESEARCH USING HUMAN MOTOR NEURONS </title>
      <link>http://www.californiastemcell.com/cgi-bin/pressrel?1211262551</link>
      <description>California Stem Cell, Inc. (CSC) today announced that it has signed a contract to supply international...</description>
      <pubDate>Wed, 31 Dec 1969 16:33:28 -0800</pubDate>
      <author></author>
    </item>

    <item>
      <title>THERAPEUTIC APPROACH DEVELOPED BY CSC SCIENTIFIC ADVISORY BOARD MEMBERS ENTERS PHASE 2 CLINICAL TRIALS</title>
      <link>http://www.californiastemcell.com/cgi-bin/pressrel?1210839821</link>
      <description>Medarex, Inc. (Nasdaq: MEDX)&#xD; announced today that it has initiated the Phase 2 clinical development...</description>
      <pubDate>Wed, 31 Dec 1969 16:33:28 -0800</pubDate>
      <author></author>
    </item>

    <item>
      <title>CALIFORNIA STEM CELL, INC. CONCLUDES SERIES A FINANCING</title>
      <link>http://www.californiastemcell.com/cgi-bin/pressrel?1204244471</link>
      <description>California Stem Cell, Inc. (CSC) has secured Series A financing from private investors.  Proceeds will...</description>
      <pubDate>Wed, 31 Dec 1969 16:33:28 -0800</pubDate>
      <author></author>
    </item>

    <item>
      <title>SAFETY STUDIES LEADING TO FDA APPLICATION FOR STEM CELL THERAPY IN SMA WILL BEGIN IN EARLY 2008</title>
      <link>http://www.californiastemcell.com/cgi-bin/pressrel?1203425660</link>
      <description>Families of Spinal Muscular Atrophy (FSMA); a stem cell scientist at University of California, Irvine...</description>
      <pubDate>Wed, 31 Dec 1969 16:33:28 -0800</pubDate>
      <author></author>
    </item>
  </channel>
</rss>

